IMVT
#1039
Immunovant, Inc. - Common Stock
38.7 7 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+0.18%
Monthly Change
+16.74%
6 month change
+51.33%
Year Change
+101.82%
Previous Close
38.7 0
Open
38.7 7
Low
38.7 7
High
38.7 7
Volume
154
Financials
- Market Capitalization 7.96 B
- Employee 315
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1022 |  IBRX ImmunityBio, Inc. - Common Stock | 7.88 USD | +1.16% | -9.43% | +10.67% | +184.48% | 8.25 B USD | ||
| 1032 |  PCVX Vaxcyte, Inc. - Common Stock | 56.21 USD | -1.44% | -6.33% | +13.40% | +32.88% | 8.12 B USD | ||
| 1057 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 61.98 USD | +1.71% | -7.80% | +18.74% | +56.34% | 7.75 B USD | ||
| 1072 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 109.96 USD | +2.30% | -2.47% | +20.91% | -0.32% | 7.54 B USD |
Frequently asked questions about Immunovant, Inc. - Common Stock
What is the Immunovant, Inc. - Common Stock stock price today?
The current price of Immunovant, Inc. - Common Stock (IMVT) is 38.77. Over the past 24 hours, the stock has changed by +0.18%. Follow the IMVT chart for real-time price dynamics.
What is the stock ticker of Immunovant, Inc. - Common Stock?
Immunovant, Inc. - Common Stock trades under the ticker IMVT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Immunovant, Inc. - Common Stock stock going up?
IMVT has changed by -1.02% over the last week, +16.74% over the last month, and +101.82% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Immunovant, Inc. - Common Stock net income for the last quarter?
Immunovant, Inc. - Common Stock reported net income of -147.86 M for the last quarter. The previous quarter showed -110.64 M, which means net income changed by -33.64%.
How many employees does Immunovant, Inc. - Common Stock have?
As of the latest available data, Immunovant, Inc. - Common Stock has 315 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Immunovant, Inc. - Common Stock stock?
You can buy Immunovant, Inc. - Common Stock (IMVT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Immunovant, Inc. - Common Stock stock?
Investing in Immunovant, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the IMVT chart and related analysis on metatrader.com as part of your research.